Literature DB >> 18571376

Attitudes of patients and family members towards implantable psychiatric medication.

Mary E Dankert1, Colleen M Brensinger, Kayla L Metzger, Chunbo Li, Svetlinka G Koleva, Andrea Mesén, Béatrice Laprade, Tjhin Wiguna, Changsu Han, Saeed Farooq, W Emanuel Severus, Jocelyn G Gayares, Jens M Langosch, Xavier Lallart, Masaru Tateno, Adriana Mihai, Sudha R N Nair, Robert Belmaker, Janusz Rybakowski, Björn Owe-Larsson, John M Kane, Eve C Johnstone, Donald J MacIntyre, Sameer Malhotra, Ana González-Pinto, Fernando Mosquera, Suzann M Babb, Ehsan Habib pour, Seyedeh Sedigheh Fatemi, Charles Swanson, Caleb Adler, Allan Young, Fumiko Hoeft, Kandiah Sivakumar, Petya D Radoeva, Elise A Lallart, Warren B Bilker, Steven J Siegel.   

Abstract

INTRODUCTION: Medication is a necessary part of treatment for severe psychiatric illnesses such as schizophrenia and nonadherence to prescribed medication is one of the most important public health issues in psychiatry today. The devastating consequences of nonadherence have motivated the development of novel therapeutic strategies, including a new long-term implantable medication delivery system.
METHODS: The current study assesses attitudes towards implantable medication in psychiatric patients and their family members. Patients included in the study had diagnoses of Schizophrenia, Schizoaffective Disorder, Mood or Anxiety related disorders.
RESULTS: 49.62% of patients and 74.47% of family members endorse support for implantable medication.
CONCLUSIONS: This study demonstrates that implants may be an acceptable alternative to oral and injectable medication for a subset of psychiatric patients and their families.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18571376     DOI: 10.1016/j.schres.2008.05.008

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  1 in total

1.  A survey of patient acceptability of repetitive transcranial magnetic stimulation (TMS) during pregnancy.

Authors:  Deborah R Kim; Laura Sockol; Jacques P Barber; Marian Moseley; Lisa Lamprou; Karl Rickels; John P O'Reardon; C Neill Epperson
Journal:  J Affect Disord       Date:  2010-09-22       Impact factor: 4.839

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.